Drug combination for cardiology patients approved
The European Medicines Agency has approved the oral antiplatelet drug ticagrelor (Brilique) for use in combination with aspirin.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units